Rezatapopt
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rezatapopt, covering 2026-02-18 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. [Phase 1]